Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|February 2, 2024
Small intestinal obstruction secondary to kinetic sand ingestion in a dogAndrew J Trempe, Jeanine M Persano
European Review for Medical and Pharmacological Sciences|February 12, 2021
Real-world study on the effectiveness and safety of basal insulin IDegLira in type 2 diabetic patients previously treated with multi-injective insulin therapyM Persano, L Nollino, M Sambataro, et al.
International Journal of Endocrinology|December 24, 2013
Estrogens as antioxidant modulators in human fertilityA Mancini, S Raimondo, M Persano, et al.
European Review for Medical and Pharmacological Sciences|July 17, 2014
Comparison of plasma antioxidant levels in middle-aged and old male with idiopatic osteoporosis: preliminary dataA Mancini, S Raimondo, C Di Segni, et al.
ESMO Open|April 13, 2024
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide datasetM M Germani, G Vetere, F Santamaria, et al.
ESMO Open|June 13, 2022
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experienceA Boccaccino, B Borelli, R Intini, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatmentF Rossari, D Lavacchi, E Alimenti, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experienceM Rimini, S Presi, K Mohammadi, et al.
ESMO Gastrointestinal Oncology|May 22, 2026
Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort studyH Vandeputte, A Casadei-Gardini, F Peeters, et al.
ESMO Open|July 6, 2026
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysisS Camera, A Vogel, M Rimini, et al.
Pageof 1